Movement Disorders
News
FDA approves first drug to treat hallucinations in Parkinson’s psychosis
News
Parkinson’s disease psychosis drug gets favorable review from FDA advisory panel
News
Parkinson’s disease psychosis drug gets favorable review from FDA advisory panel
Commentary
Prion-like transmission of neurodegenerative pathology stirs concern
Recent developments regarding the nature of transmissible pathologic proteins in a variety of common neurodegenerative diseases – including...
News
CSF markers differentiate Parkinson’s, predict related dementia
Key clinical point: CSF markers may help differentiate Parkinson’s disease from other sources of parkinsonism. Major finding: A pattern of high...
Conference Coverage
PAS: Mind-body practices benefit teens with chronic illnesses
Key clinical point: A mind-body and peer support program helps teens with chronic illness. Major finding: Teens who participated in up to 10...
Conference Coverage
AAN: Scheduled daily DBS effective in small Tourette syndrome study
Key clinical point: Promising results of a tailored approach to deep brain stimulation in three patients with Tourette syndrome merits a larger...
Conference Coverage
AAGP: Treating Parkinson’s psychosis takes balance on risk/benefit tightrope
Conference Coverage
Pathologic proteins in Alzheimer’s, Parkinson’s also collect in skin cells
Key clinical point: The abnormal brain proteins of Alzheimer’s and Parkinson’s may also be expressed in skin cells. Major finding: Tau and alpha-...